
1. J Infect. 2015 Nov;71(5):571-7. doi: 10.1016/j.jinf.2015.07.006. Epub 2015 Jul
23.

Hepatitis C virus reinfection after sustained virological response in
HIV-infected patients with chronic hepatitis C.

Pineda JA(1), Núñez-Torres R(2), Téllez F(3), Mancebo M(4), García F(5),
Merchante N(4), Pérez-Pérez M(3), Neukam K(4), Macías J(4), Real LM(4); HEPAVIR
Group of The Andalusian Society of Infectious Diseases (SAEI).

Author information: 
(1)Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital
Universitario de Valme, Avda. de Bellavista s/n, 41014 Sevilla, Spain. Electronic
address: japineda@telefonica.net.
(2)Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital
Universitario de Valme, Avda. de Bellavista s/n, 41014 Sevilla, Spain.
(3)Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital La Línea,
AGS Campo de Gibraltar, Avda. Menéndez Pelayo 103, 11300 La Línea de la
Concepción, Cádiz, Spain.
(4)Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital
Universitario de Valme, Avda. de Bellavista s/n, 41014 Sevilla, Spain; Instituto 
de Biomedicina de Sevilla (IBiS), Campus Universitario Virgen del Rocío, Avda.
Manuel Siurot s/n, 41013 Sevilla, Spain.
(5)Servicio de Microbiología, Complejo Hospitalario Universitario de Granada,
Centro San Cecilio-PTS, C. Dr. Oloriz, 18012 Granada, Spain.

OBJECTIVES: To assess the incidence of hepatitis C virus (HCV) reinfections after
therapy-induced clearance in HIV-coinfected patients with prior chronic hepatitis
C.
METHODS: Eighty-four HIV-infected subjects, who had previously achieved sustained
virological response (SVR) after being treated of chronic hepatitis C, were
analyzed. In all of them, at least yearly HCV RNA determinations were carried out
during a median (range) of 34 (12-146) months.
RESULTS: Seventy-two (86%) subjects had been people who inject drugs (PWID), of
whom 11 (15%) continued to use snorted or injected drugs during the follow-up.
Four (4.76%) patients showed HCV reinfection (incidence 1.21 [95% confidence
interval: 0.3-3.09] cases per 100 person-years). These patients maintained risk
factors for HCV infection. In three cases, HCV genotype switched. Phylogenetic
analysis of the remaining case suggested reinfection from his sexual partner.
CONCLUSION: The incidence of HCV reinfection in the overall population of
HIV-coinfected patients who achieved SVR after being treated against chronic
hepatitis C is low. A low frequency of risk behavior is the main factor
accounting for this modest rate of reinfection. The possibility of reinfection
should not be considered a reason against treatment of HCV infection with direct 
acting antivirals in PWID.

Copyright © 2015 The British Infection Association. Published by Elsevier Ltd.
All rights reserved.

DOI: 10.1016/j.jinf.2015.07.006 
PMID: 26212868  [Indexed for MEDLINE]

